Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients

R. E. A. Tjon Pian Gi*, T. Ilmarinen, E. R. van den Heuvel, L. M. Aaltonen, J. Andersen, J. W. Brunings, M. Chirila, A. Dietz, F. Ferran Vila, G. Friedrich, H. H. W. de Gier, W. Golusinski, M. Graupp, A. Hantzakos, R. Horcasitas, J. Jackowska, J. C. Koelmel, G. Lawson, F. Lindner, M. RemacleC. Sittel, V. Weichbold, M. Wierzbicka, F. G. Dikkers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1679-1687
JournalEuropean Archives of Oto-Rhino-Laryngology
Issue number5
Publication statusPublished - May 2013


  • Recurrent respiratory papillomatosis
  • RRP
  • Laryngeal papilloma
  • Cidofovir
  • Side effects
  • Nephrotoxicity
  • Neutropenia
  • Malignancy

Cite this